Literature DB >> 23614566

Potential role of CYP2D6 in the central nervous system.

Jie Cheng1, Yueying Zhen, Sharon Miksys, Diren Beyoğlu, Kristopher W Krausz, Rachel F Tyndale, Aiming Yu, Jeffrey R Idle, Frank J Gonzalez.   

Abstract

1. Cytochrome P450 2D6 (CYP2D6) is a pivotal enzyme responsible for a major drug oxidation polymorphism in human populations. Distribution of CYP2D6 in brain and its role in serotonin metabolism suggest that CYP2D6 may have a function in the central nervous system. 2. To establish an efficient and accurate platform for the study of CYP2D6 in vivo, a human CYP2D6 (Tg-2D6) model was generated by transgenesis in wild-type (WT) C57BL/6 mice using a P1 phage artificial chromosome clone containing the complete human CYP2D locus, including the CYP2D6 gene and 5'- and 3'-flanking sequences. 3. Human CYP2D6 was expressed not only in the liver but also in the brain. The abundance of serotonin and 5-hydroxyindoleacetic acid in brain of Tg-2D6 is higher than in WT mice, either basal levels or after harmaline induction. Metabolomics of brain homogenate and cerebrospinal fluid revealed a significant up-regulation of L-carnitine, acetyl-L-carnitine, pantothenic acid, 2'-deoxycytidine diphosphate (dCDP), anandamide, N-acetylglucosaminylamine and a down-regulation of stearoyl-L-carnitine in Tg-2D6 mice compared with WT mice. Anxiety tests indicate Tg-2D6 mice have a higher capability to adapt to anxiety. 4. Overall, these findings indicate that the Tg-2D6 mouse model may serve as a valuable in vivo tool to determine CYP2D6-involved neurophysiological metabolism and function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23614566      PMCID: PMC3750078          DOI: 10.3109/00498254.2013.791410

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  63 in total

1.  Metabolism of debrisoquine sulfate. Identification of some urinary metabolites in rat and man.

Authors:  J G Allen; P B East; R J Francis; J L Haigh
Journal:  Drug Metab Dispos       Date:  1975 Sep-Oct       Impact factor: 3.922

2.  A technique for the collection of cerebrospinal fluid from mice.

Authors:  C M Vogelweid; A B Kier
Journal:  Lab Anim Sci       Date:  1988-02

3.  Swimming rats and human depression.

Authors:  J Hawkins; R A Hicks; N Phillips; J D Moore
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

4.  A possible alarm substance in the forced swimming test.

Authors:  E L Abel; P J Bilitzke
Journal:  Physiol Behav       Date:  1990-08

5.  Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.

Authors:  H H Berendsen; C L Broekkamp
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

6.  Significance of central noradrenergic system on harmaline induced tremor.

Authors:  M Yamazaki; C Tanaka; S Takaori
Journal:  Pharmacol Biochem Behav       Date:  1979-03       Impact factor: 3.533

7.  The metabolism of [14C]-debrisoquine in man.

Authors:  J R Idle; A Mahgoub; M M Angelo; L G Dring; R Lancaster; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

8.  Fatty acid oxidation in rat brain is limited by the low activity of 3-ketoacyl-coenzyme A thiolase.

Authors:  S Y Yang; X Y He; H Schulz
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

9.  Metabolism of debrisoquine sulphate in rat, dog and man.

Authors:  J G Allen; A N Brown; T R Marten
Journal:  Xenobiotica       Date:  1976-07       Impact factor: 1.908

10.  Polymorphic hydroxylation of Debrisoquine in man.

Authors:  A Mahgoub; J R Idle; L G Dring; R Lancaster; R L Smith
Journal:  Lancet       Date:  1977-09-17       Impact factor: 79.321

View more
  18 in total

Review 1.  Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.

Authors:  Timothy S Tracy; Amarjit S Chaudhry; Bhagwat Prasad; Kenneth E Thummel; Erin G Schuetz; Xiao-Bo Zhong; Yun-Chen Tien; Hyunyoung Jeong; Xian Pan; Laura M Shireman; Jessica Tay-Sontheimer; Yvonne S Lin
Journal:  Drug Metab Dispos       Date:  2015-12-17       Impact factor: 3.922

2.  Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Neuropharmacology       Date:  2015-02       Impact factor: 5.250

Review 3.  Addressing phenoconversion: the Achilles' heel of personalized medicine.

Authors:  Rashmi R Shah; Robert L Smith
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

Review 4.  P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.

Authors:  Karl-Dimiter Bissig; Weiguo Han; Mercedes Barzi; Nataliia Kovalchuk; Liang Ding; Xiaoyu Fan; Francis P Pankowicz; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

5.  Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.

Authors:  Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Pharmacol Rep       Date:  2016-02-05       Impact factor: 3.024

6.  Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.

Authors:  R T Miller; S Miksys; E Hoffmann; R F Tyndale
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

7.  Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics.

Authors:  Jessica Tay-Sontheimer; Laura M Shireman; Richard P Beyer; Taurence Senn; Daniela Witten; Robin E Pearce; Andrea Gaedigk; Cletus L Gana Fomban; Justin D Lutz; Nina Isoherranen; Kenneth E Thummel; Oliver Fiehn; J Steven Leeder; Yvonne S Lin
Journal:  Pharmacogenomics       Date:  2014-12       Impact factor: 2.533

8.  Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.

Authors:  Cole Tolledo; Marlaina R Stocco; Sharon Miksys; Frank J Gonzalez; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2020-03-18       Impact factor: 5.590

9.  Propranolol is a mechanism-based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6-transgenic mice: Effects on activity and drug responses.

Authors:  Edgor Cole Tolledo; Sharon Miksys; Frank J Gonzalez; Rachel F Tyndale
Journal:  Br J Pharmacol       Date:  2020-01-06       Impact factor: 8.739

10.  Human CYP2D6 in the Brain Is Protective Against Harmine-Induced Neurotoxicity: Evidence from Humanized CYP2D6 Transgenic Mice.

Authors:  Marlaina R Stocco; Cole Tolledo; Fariba Baghai Wadji; Frank J Gonzalez; Sharon Miksys; Rachel F Tyndale
Journal:  Mol Neurobiol       Date:  2020-08-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.